[go: up one dir, main page]

US2072829A - N-metbrax-c - Google Patents

N-metbrax-c Download PDF

Info

Publication number
US2072829A
US2072829A US2072829DA US2072829A US 2072829 A US2072829 A US 2072829A US 2072829D A US2072829D A US 2072829DA US 2072829 A US2072829 A US 2072829A
Authority
US
United States
Prior art keywords
weight
allyl
parts
isopropyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US2072829A publication Critical patent/US2072829A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Definitions

  • N-methyl-C,C-allylisopropyl-barbituric acid possesses valuable therapeutic properties. I'he new compound is particularly well suited for narcotic purposes.
  • N-methyl-C,C-allyl-isopropyl-barbituric acid is obtained by the action of methylating agents on C,C-allyl-isopropyl-barbituric acid, of allyl halides on N-methyl-C-isopropyl-barbituric acid or of methyl-carbamide on allyl-isopropyl-malonicester.
  • N-methyl-C,C-allyl-isopropyl-barbituric acid melts at 56-57 C. It is easily soluble in the usual organic solvents, difficultly soluble in water and is to be used for therapeutic purposes.
  • Example 1 210 parts by weight of C,C-allyl-isopropyl-barbituric acid are dissolved in 1300 parts by weight of water and 118.7 parts by weight of 33.7% sodium hydroxide solution. While stirring 126 parts by weight of dimethyl sulphate are dropped into the solution. Reaction takes place immediately with evolution of heat. The reaction product is precipitated as an oil. For removing small quantities of tetra-alkyl-barbituric acid which may be present, the reaction product is treated with 118.7 parts by weight of 33.7% sodium hydroxide solution, whereby the tri-alkylbarbituric acid is again dissolved. The tetraalkyl-barbituric acid may then be removed by filtration or extraction.
  • N-methyl-C,C-allyl-isopropyl-barbituric acid is precipitated by the addition of acid. It may be purified by distillation in vacuo (boiling point l76-178 C./ 12 mm.), or by crystallization from dilute alcohol or petroleum ether and melts at 56-57 C.
  • the whole quantity of sodium hydroxide solution may also be added at the beginning without detrimental effect on the methylation with di- Example 2 184 parts by weight of N-methyl-C-isopropylharbituric acid are dissolved in 900 parts by Weight of water and 133 parts by weight of 30% sodium hydroxide solution. Hereafter 121 parts by Weight of allyl bromide are added and stirred at 30-35 C. until the allyl bromide has disappeared.
  • the N-methyl-C,C-allyl-isopropyl-barbituric acid thus obtained is purified either by distillation in vacuo (boiling point 176-173 C./12 mm.) or by crystallization from dilute alcohol or petroleum ether.
  • the transformation may be carried out more quickly and. at a lower temperature if small quantities of copper or of copper compounds are added as described in the process of German Patent No. 526,854.
  • Example 3 To a solution of 57 parts by weight of sodium in 630 parts by weight of absolute alcohol 110 parts by weight of methyl carbamide and 242 parts by weight of isopropyl-allyl-malonic-ester are added. The Whole mixture is heated for 6-8 hours in an autoclave to C. The alcohol is then removed by distillation. The residue is dissolved in ice Water and acidified after filtration. The precipitated Nmethyl-C,C-allyl-isopropyl-barbituric acid is purified either by distillation in vacuo or by crystallization from dilute alcohol or from petroleum ether.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Patented Mar. 2, 1937 EATT OFFEE Otto Schnider, Basel, Switzerland, assignor to Hoifrnann-La Roche Inc, Nutley, N. 3., a corporation of New Jersey No Drawing. Application May 8, 1936, Serial No. 78,733. In Switzerland May 17, 1935 1 Claim.
It has been found that N-methyl-C,C-allylisopropyl-barbituric acid possesses valuable therapeutic properties. I'he new compound is particularly well suited for narcotic purposes.
5 By intravenous injection of aqueous solutions of the sodium salt deep narcosis is obtained which by further slow injection may be kept at the profound stage necessary for surgical operations.
N-methyl-C,C-allyl-isopropyl-barbituric acid is obtained by the action of methylating agents on C,C-allyl-isopropyl-barbituric acid, of allyl halides on N-methyl-C-isopropyl-barbituric acid or of methyl-carbamide on allyl-isopropyl-malonicester.
N-methyl-C,C-allyl-isopropyl-barbituric acid melts at 56-57 C. It is easily soluble in the usual organic solvents, difficultly soluble in water and is to be used for therapeutic purposes.
Example 1 210 parts by weight of C,C-allyl-isopropyl-barbituric acid are dissolved in 1300 parts by weight of water and 118.7 parts by weight of 33.7% sodium hydroxide solution. While stirring 126 parts by weight of dimethyl sulphate are dropped into the solution. Reaction takes place immediately with evolution of heat. The reaction product is precipitated as an oil. For removing small quantities of tetra-alkyl-barbituric acid which may be present, the reaction product is treated with 118.7 parts by weight of 33.7% sodium hydroxide solution, whereby the tri-alkylbarbituric acid is again dissolved. The tetraalkyl-barbituric acid may then be removed by filtration or extraction. From the solution of its sodium salt N-methyl-C,C-allyl-isopropyl-barbituric acid is precipitated by the addition of acid. It may be purified by distillation in vacuo (boiling point l76-178 C./ 12 mm.), or by crystallization from dilute alcohol or petroleum ether and melts at 56-57 C.
The whole quantity of sodium hydroxide solution may also be added at the beginning without detrimental effect on the methylation with di- Example 2 184 parts by weight of N-methyl-C-isopropylharbituric acid are dissolved in 900 parts by Weight of water and 133 parts by weight of 30% sodium hydroxide solution. Hereafter 121 parts by Weight of allyl bromide are added and stirred at 30-35 C. until the allyl bromide has disappeared. The N-methyl-C,C-allyl-isopropyl-barbituric acid thus obtained is purified either by distillation in vacuo (boiling point 176-173 C./12 mm.) or by crystallization from dilute alcohol or petroleum ether.
The transformation may be carried out more quickly and. at a lower temperature if small quantities of copper or of copper compounds are added as described in the process of German Patent No. 526,854.
Example 3 To a solution of 57 parts by weight of sodium in 630 parts by weight of absolute alcohol 110 parts by weight of methyl carbamide and 242 parts by weight of isopropyl-allyl-malonic-ester are added. The Whole mixture is heated for 6-8 hours in an autoclave to C. The alcohol is then removed by distillation. The residue is dissolved in ice Water and acidified after filtration. The precipitated Nmethyl-C,C-allyl-isopropyl-barbituric acid is purified either by distillation in vacuo or by crystallization from dilute alcohol or from petroleum ether.
1 claim:
N-methyl-C,C-allyl-isopropyl-barbiturio acid melting at 56-57 C., boiling at 176-178" C./12 mm., being easily soluble in the usual organic solvents and possessing valuable therapeutic properties.
OTTO SCHNIDER.
US2072829D N-metbrax-c Expired - Lifetime US2072829A (en)

Publications (1)

Publication Number Publication Date
US2072829A true US2072829A (en) 1937-03-02

Family

ID=3428537

Family Applications (1)

Application Number Title Priority Date Filing Date
US2072829D Expired - Lifetime US2072829A (en) N-metbrax-c

Country Status (1)

Country Link
US (1) US2072829A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868790A (en) * 1959-01-13 Manufacture of barbituric compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868790A (en) * 1959-01-13 Manufacture of barbituric compounds

Similar Documents

Publication Publication Date Title
US2353725A (en) Dihydroxy halogenated diphenyl methanes and process for making same
US1894865A (en) Basic ether of aromatic ketones
DE1443591A1 (en) Glucofuranosides and processes for their preparation
US2072829A (en) N-metbrax-c
US2354012A (en) Dihydroxy halogenated diphenyl methanes and process for making same
US2485146A (en) Manufacture of chloro cresoxy acetic acid
US2465293A (en) Synthesis of 4-hydroxycoumarins
US591483A (en) Coora
US2081712A (en) Local anaesthetically active pharmaceutical preparation and method of preparing the sme
DE1643329A1 (en) Process for the preparation of nitroaminodiarylaethers
US2354013A (en) Dihydroxy halogenated diphenyl methanes and process for making same
US2272267A (en) Alkaline earth metal salts of dihydroxy hexachloro diphenyl methane
US2228166A (en) Basic double ethers of quinoline series and a process of preparing them
US2529865A (en) Pyridylalkyl esters of aromatic substituted acetic acids
McKenzie et al. CXLIII.—Some derivatives of desylamine
AT163638B (en) Process for the preparation of methylchlorophenoxyalkylcarboxylic acid compounds
DE616786C (en) Process for the preparation of alkylated phenols
US1894375A (en) Basic product and process of making it
US2212532A (en) Ethers of trimethylhydroquinone and process of preparing them
US1941207A (en) 3-carboxy-4-hydroxy-diphenyl and salts thereof
DE85988C (en)
US1906221A (en) Hydroxy-diphenylindoles
US2864824A (en) Alkoxy derivatives of 3:5-dioxo-pyrazolidene and process for their manufacture
Farinholt et al. The Preparation of Certain Cryptophenols
AT163637B (en) Process for the preparation of 2,4-dichlorophenoxy compounds